Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Cidara Therapeutics
Cidara Therapeutics
(CDTX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Rezzayo
Rezafungin
2023-03-22
2032-2038
Candidemia
,
Invasive candidiasis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Rezafungin
healthy volunteers/patients
,
vulvovaginal candidiasis
,
mycoses
,
candidemia
,
invasive candidiasis
,
fungemia
,
pneumocystis
,
aspergillus
,
invasive hydatidiform mole
Sodium chloride
healthy volunteers/patients
,
human influenza
,
candidemia
,
invasive candidiasis
,
mycoses
,
fungemia
,
pneumocystis
,
aspergillus
,
invasive hydatidiform mole
Microcrystalline cellulose
candidemia
,
invasive candidiasis
,
mycoses
,
fungemia
,
pneumocystis
,
aspergillus
,
invasive hydatidiform mole
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use